AzTrials
AzTrials

Chronic Low-back PainNCT05823857

Effect of an Aquatic Exercise Program in Patients With Chronic Low Back Pain

A study testing Aquatic Therapy in people with Chronic Low-back Pain and Muscle Atrophy, run by Concordia University, Montreal at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this pilot randomized controlled trial is to compare the effects of aquatic therapy versus standard care on paraspinal and gluteal morphology and function in individuals with chronic low back pain.The main questions it aims to answer are: 1. Read more about this study

Who is it for?
Ages 18 to 65 years
What is being tested?
Aquatic Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
34 participants
Where
1 siteCanada
Study dates
1 Nov 2022to 18 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • chronic nonspecific LBP (>3 months), defined as pain in the region between the lower ribs and gluteal folds, with or without leg pain
  • currently seeking care for LBP
  • aged between 18 and 65 years old
  • English or French speakers
  • have a score of "moderate" or "severe" disability on the modified Oswestry Low Back Questionnaire
  • do not currently engaged in sports or fitness training specifically for the lower back muscles (3 months prior the beginning of the trial).

Who cannot join

  • evidence of nerve root compression or reflex motor signs deficits
  • previous spinal surgery or vertebral fractures
  • other major lumbar spine structural abnormalities
  • comorbid health conditions that would prevent active participation in exercise programs

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • PERFORM Centre

    Montreal, Quebec, H4B 1R6

Other trials in Canada

About this study

Official title: Effect of Aquatic Exercise on Paraspinal and Gluteal Morphology and Function in Patients With Chronic Low Back Pain

The goal of this pilot randomized controlled trial is to compare the effects of aquatic therapy versus standard care on paraspinal and gluteal morphology and function in individuals with chronic low back pain.The main questions it aims to answer are:

  1. What are the effects of aquatic therapy versus standard care on a) paraspinal and gluteal muscle size, composition (e.g., fatty infiltration) and b) lumbar and gluteal muscle strength in individuals with chronic LBP?
  2. Is aquatic therapy more effective than standard care to improve pain, function and psychological factors (e.g., kinesiophobia, catastrophizing, anxiety, and depression)?
  3. Is using a digital application "play the pain" feasible to monitor pain levels and the activities that participants used to cope with pain?

Participants will be assigned to either the aquatic therapy group or standard care group where they will undergo a 10-week intervention including two 60-minute session per week.

Being tested
Aquatic Therapy, Standard Care
Keywords
low back pain, musculoskeletal rehabilitation, aquatic therapy, standard care, diagnostic imaging, muscle morphology, randomized controlled trial
Medical subject headings
Muscular Atrophy, Low Back Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Aquatic TherapyOther

    Participants in this experimental intervention group will perform trunk stabilization, which will be based on a variety of aquatic exercises in different positions, intended to activate the multifidus and transverse abdominis in a co-contraction. Additionally, hip exercises will be completed to promote the strengthening of the gluteus maximus, gluteus medius, and gluteus minimus muscles. The aim of these exercises is to enhance the strength and dynamic stability of the spine and its surrounding musculature in a functional and yet non-weight-bearing way. Each exercise will be performed 10 times while sustaining the muscles co-contraction for 5-10 seconds and will be progressed gradually. Each training session (60 minutes) will be supervised by a Certified Athletic Therapist and take place in the PERFORM AT Clinic/Swim Ex pool.

  • Standard CareOther

    Participants in this experimental intervention group will receive the standard LBP treatment in the PERFORM Athletic Therapy clinic.Two Certified Athletic Therapists (AT) will be conducting the sessions. The ATs will complete a thorough assessment of the eligible participants with chronic LBP and administer a range of interventions including stretching, strengthening and stabilization exercise, aerobic conditioning, and manual mobilization techniques. Other modalities could include application of ice and heat, ultrasound, and transcutaneous electrical nerve stimulation (TENS).

Study groups in NCT05823857
Study groupRoleWhat they receive
Aquatic TherapyExperimentalAquatic exercise program including trunk stabilization, upper body, lower body strengthening and flexibility exercises and aerobic conditioning. Supervised 10-week program, 2 times a week.
Receives: Other: Aquatic Therapy
Standard CareExperimentalStandard care program including strengthening, flexibility, aerobic conditioning, modalities and manual mobilization techniques. Supervised 10-week program, 2 times a week.
Receives: Other: Standard Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in multifidus muscle size (cross-sectional area) in cm^2

    Multifidus muscle cross-sectional area measurements will be obtained from magnetic resonance imaging (MRI).

    Measured: Baseline, 10-week

  2. Change in gluteal muscle size (cross-sectional area) in cm^2

    Gluteal muscle cross-sectional area measurements will be obtained from magnetic resonance imaging (MRI).

    Measured: Baseline, 10-week

  3. Percent change in multifidus muscle fatty infiltration in

    Multifidus muscle fatty infiltration (composition) measurements will be obtained from magnetic resonance imaging (MRI).

    Measured: Baseline, 10-week

  4. Percent change in gluteal muscle fatty infiltration

    Gluteal muscle fatty infiltration (composition) measurements will be obtained from magnetic resonance imaging (MRI).

    Measured: Baseline, 10-week

Secondary outcomes (8)
  1. Point score change in12-item Short Form Health Survey (SF-12)

    The 12-item Short Form Health Survey (SF-12) is the condensed form of the previous 36-item SF-12 Survey. The SF-12 is used to assess health-related quality of life. The 12-item survey consists of 8 domains that assess both physical and mental health composite scores (PCS and MCS). While the SF-12 is weighted and summed to provide a score for both the PCS and MCS. The score of the 12 questions can range from 0 (worst level of health) to 100 (highest level of health).

    Measured: Baseline, 10-week

  2. Point score change in Oswestry Low Back Pain Disability Index (ODI) score

    The ODI is used to measure the patient's level of disability in relation to LBP. It is a 10-item scale where each item is rated from 0-6. Higher scores are indicative of greater disability.

    Measured: Baseline, 10-week

  3. Point score change in Tampa Scale of Kinesiophobia (TSK)

    The TSK measures pain-related fear in an individual through a 13-item scale. The scores range between 17 and 68 with increasing scores indicating a greater level of kinesiophobia.

    Measured: Baseline, 10-week

  4. Point score change in The Pain Catastrophizing Scale (PCS)

    The PCS is a 13-item questionnaire that assesses an individual's level of catastrophizing. Each item is rated from 0-4 for a possible total of 52. Higher scores are indicative of a greater level of catastrophizing.

    Measured: Baseline, 10-week

  5. Point score change in The Hospital Anxiety and Depression Scale (HADS)

    The HADS is a 14-item questionnaire used to assess a patient's level of depression and anxiety. Each item is rated from 0-3 with either depression or anxiety having scores between 0 and 21. Higher scores are indicative of greater levels of anxiety and depression.

    Measured: Baseline, 10-week

  6. Point score change in Insomnia Severity Index (ISI)

    The ISI is a 7-item questionnaire used to assess sleep disturbances. Each item is rated from 0 to 4 and the total score is added. Higher scores are indicative of greater sleep disturbances.

    Measured: Baseline, 10-week

  7. Point score change in The International Physical Activity Questionnaire (IPAQ)

    The IPAQ is a self-reported log of metabolic equivalent (MET)-minutes per week. The level of physical activity is rated either vigorous, moderate, walking and sitting and must be assigned to the right category. The number of minutes per category is then added up and assessed.

    Measured: Baseline, 10-week

  8. Point score change in Visual Numerical pain rating scale (NPR)

    The NPR for pain is a rating system from 0 to 10 with 0 being no pain and 10 worst pain imaginable.

    Measured: Baseline, 10-week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Apr 2023
  2. Study start1 Nov 2022
  3. Primary completion18 Dec 2023
  4. Study completion18 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Pilot randomized controlled trial
Masking
None (open label)
Enrolment
34 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05823857
Sponsor's protocol ID
CCER-21-22-35
Status last verified
Nov 2024
First submitted
10 Apr 2023
Last updated
1 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Montpetit C, Vaillancourt N, Rosenstein B, Wesselink EO, Dover G, Weiss C, Papula LA, Melek A, Weber KA, Elliott JM, Fortin M. Effects of aquatic therapy vs. standard care on gluteal muscle morphology and function in individuals with chronic low back pain: a randomized controlled trial. BMC Sports Sci Med Rehabil. 2026 Apr 6;18(1):241. doi: 10.1186/s13102-026-01666-0.

    PubMed 41943153
  • Vaillancourt N, Montpetit C, Rosenstein B, Fortin M. Aquatic therapy compared to standard care for chronic low back pain: a randomized controlled trial. Pain Manag. 2026 Apr;16(4):309-321. doi: 10.1080/17581869.2026.2613633. Epub 2026 Jan 13.

    PubMed 41527881
  • Rosenstein B, Montpetit C, Vaillancourt N, Dover G, Khalini-Mahani N, Weiss C, Papula LA, Melek A, Fortin M. Effect of aquatic exercise versus standard care on paraspinal and gluteal muscles morphology in individuals with chronic low back pain: a randomized controlled trial protocol. BMC Musculoskelet Disord. 2023 Dec 18;24(1):977. doi: 10.1186/s12891-023-07034-0.

    PubMed 38110922

Questions about this trial

What is this clinical trial studying?

A study testing Aquatic Therapy in people with Chronic Low-back Pain and Muscle Atrophy, run by Concordia University, Montreal at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in multifidus muscle size (cross-sectional area) in cm^2 (time frame: Baseline, 10-week). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05823857, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jul 2025; AzTrials last refreshed its copy on 1 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in